Contributors

About the Authors

  • The Authors of "Patent Docs" are patent attorneys who hold doctorates in a diverse array of biotech and chemical disciplines.

Contact the Docs

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter. When a new article is posted during the day, you will receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

« Affymetrix to Buy USB Corp. | Main | Otsuka Pharmaceutical Co. and PDL BioPharma Strike Deal for IV Busulfex »

December 18, 2007

New Briefing Deadline Set In PTO Rules Case

    By Kevin E. Noonan --

Eastern_district_of_virginia_seal Judge James C. Cacheris of the U.S. District Court for the Eastern District of Virginia today extended until December 27th the deadline for the parties to file summary judgment motions regarding the merits of plaintiffs' complaint seeking a permanent injunction against implementation of the misguided "new rules" relating to continuation and claims limitation practices.  The deadline for amicus filings (for the amici who have already had their motions for leave to file an amicus brief granted) was also extended until the 27th.  No reason was given for the extension, which the court issued sua sponte, although it may be due to the on-going dispute over discovery in the case.

Glaxosmithkline_gsk To date, motions for leave to file an amicus brief have been filed by the following entities, where the filing date and any limitation in the scope of the motion is indicated in parentheses: Pharmaceutical Research and Manufacturers of America (October 26); the Biotechnology Industry Organization (October 29): Elan Pharmceuticals, Inc. (October 29 and December 6); Monsanto Co. (November 26); Intellectual Property Institute of William Mitchell College of Law (November 27); and the American Intellectual Property Lawyers Association (relating to the retroactive application of the new rules to pending applications; December 11).  Additional parties wishing to file amicus briefs should contact SMoore@KellyDrye.com, JDesmarais@Kirkland.com, and Lauren.Wetzler@usdoj.com and ask consent to file the brief and seek extension of time to December 27, and then file a motion for leave to file as amicus and for extension of time with the Court.

At least a first decision is expected some time in the spring in this case.

For additional information on this topic, please see:

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/1117334/24337984

Listed below are links to weblogs that reference New Briefing Deadline Set In PTO Rules Case:

Comments

Post a comment

May 2008

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Google Search